Highly active antiretroviral therapy (HAART) for the treatment of the human immune deficiency virus (HIV) infection has been associated with improved survival among HIV infected patients world over even among patients admitted to the intensive care unit (ICU).
Further studies are also needed to find effective ways to identify patient at risk and ways to manage the Ramadan-associated migraine exacerbation, which affects the lives of millions of Muslim migraine patients world wide, and many of them exacerbate 1 month each year.
Sadot, E, Zheng, J, Srouji, R, Strong, VE, Gönen, M, Balachandran, VP, D'Angelica, MI, Allen, PJ, DeMatteo, RP, Kingham, TP, Fong, Y, Weiser, MR, and Jarnagin, WR. "Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients". World Journal of Surgery 43, no. 2 (February 2019): 385-394.
Sadot, E, Zheng, J, Srouji, R, Strong, VE, Gönen, M, Balachandran, VP, D'Angelica, MI, Allen, PJ, DeMatteo, RP, Kingham, TP, Fong, Y, Weiser, MR, and Jarnagin, WR. "Correction to: Hypophosphatemia as a Predictor of Organ-Specific Complications Following Gastrointestinal Surgery: Analysis of 8034 Patients". World Journal of Surgery 43, no. 2 (February 2019): 395-null.
Physicians' world region of origin was defined based on medical school location and patients' world region of origin was defined based on country of birth.
World median age was obtained from a previous Feigin et al 20 review, and was found to be older than for the recruited patients (world median is 75 years; recruited median is 73 years, with a 95% CI of 72 to 74).
These trials are being conducted in thousands of patients world-wide by several of the cooperative research organizations.
Using data from 500 FOP patients (representing 63% of all known patients world-wide), age- and joint-specific risks of new joint involvement were estimated using parametric and nonparametric statistical methods.
There are, however, many diseases where there is a clear need for treatment but where there are insufficient patients world-wide to support the costs of modern drug research.
Each year, ∼500,000 patients world-wide are treated for head and neck cancer.
In addition, we analysed tumours treated with tamoxifen, one of the most common drugs used for patients world-wide.
